Table 2.
Dietetic or anthropometric variables at the start and end of the supplementation and placebo periods.
| SAx | Placebo | |||
|---|---|---|---|---|
| (n = 67) | (n = 67) | |||
| Energy | (kcal/day) | Start | 1923 ± 513.6 | 1864 ± 471.9 |
| End | 1891 ± 549.4 | 1881 ± 569.5 | ||
| Change | −31.88 ± 463.2 | 17.07 ± 355.5 | ||
| Carbohydrates | (%) | Start | 38.06 ± 6.5 | 38.46 ± 8.9 |
| End | 37.62 ± 6.3 | 39.06 ± 6.5 | ||
| Change | −0.439 ± 5.7 | 0.598 ± 8.1 | ||
| Proteins | (%) | Start | 17.24 ± 3.7 | 17.44 ± 2.9 |
| End | 17.43 ± 3.6 | 17.60 ± 3.1 | ||
| Change | 0.193 ± 4.4 | 0.164 ± 3.5 | ||
| Lipids | (%) | Start | 41.42 ± 6.3 | 40.48 ± 8.8 |
| End | 41.36 ± 5.7 | 40.19 ± 5.9 | ||
| Change | −0.067 ± 5.3 | −0.287 ± 8.0 | ||
| Weight | (kg) | Start | 65.10 ± 11.3 | 65.10 ± 11.2 |
| End | 64.93 ± 11.2 | 64.85 ± 11.3 | ||
| Change | −0.173 ± 1.3 | −0.249 ± 1.0 | ||
| BMI | (kg/m2) | Start | 24.58 ± 3.0 | 24.63 ± 3.0 |
| End | 24.51 ± 3.0 | 24.48 ± 3.0 | ||
| Change | −0.068 ± 0.5 | −0.151 ± 0.6 | ||
| Waist | (cm) | Start | 81.85 ± 9.0 | 81.24 ± 9.8 |
| circumference | End | 81.82 ± 9.6 | 81.25 ± 9.6 | |
| Change | −0.034 ± 2.9 | 0.008 ± 3.7 | ||
| FM | (%) | Start | 29.16 ± 6.6 | 28.90 ± 6.5 |
| End | 29.56 ± 6.8 | 29.79 ± 7.2 | ||
| Change | 0.400 ± 2.8 | 0.891 ± 3.7 | ||
| FFM | (%) | Start | 70.84 ± 6.6 | 71.10 ± 6.5 |
| End | 70.44 ± 6.8 | 70.21 ± 7.2 | ||
| Change | −0.400 ± 2.8 | −0.891 ± 3.7 | ||
| MM | (%) | Start | 47.63 ± 6.2 | 47.52 ± 6.5 |
| End | 46.67 ± 5.7 | 46.44 ± 5.8 | ||
| Change | −0.970 ± 5.1 | −1.082 ± 5.8 |
Data are expressed as the means ± SDs. SAx: Oral Supplementation with HT and PC; BMI: Body Mass Index; FM: Fat mass; FFM: Fat-Free Mass; MM: Muscle Mass. There are not significant differences between the start and end of the intervention periods or in the change recorded between the intervention periods.